https://ansm.sante.fr/tableau-marr/velaglucerase-alfa 2022 false false false France French risk management velaglucerase alfa, human Velaglucerase Alfa Velaglucerase Alfa guidelines for drug use infusions, intravenous drug hypersensitivity infusions, intravenous continuity of patient care velaglucerase alfa patients guideline patient safety enzyme replacement therapy gaucher disease Infusion-Related Reaction home nursing